# Task A02: Development of Small Animal Lassa Virus infection Model for the Assessment of Anti-Viral Activity of Medical Countermeasures Efficacy

> **NIH NIH N01** · UNIVERSITY OF TEXAS MED BR GALVESTON · 2024 · $1,010,897

## Abstract

This contract provides for the development of new and refinement of existing models of infectious diseases and may include evaluation of candidate countermeasures.

## Key facts

- **NIH application ID:** 11197631
- **Project number:** 75N93024D00042-0-759302400006-1
- **Recipient organization:** UNIVERSITY OF TEXAS MED BR GALVESTON
- **Principal Investigator:** DAVID BEASLEY
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $1,010,897
- **Award type:** —
- **Project period:** 2024-09-20 → 2025-09-19

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11197631

## Citation

> US National Institutes of Health, RePORTER application 11197631, Task A02: Development of Small Animal Lassa Virus infection Model for the Assessment of Anti-Viral Activity of Medical Countermeasures Efficacy (75N93024D00042-0-759302400006-1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/11197631. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*